Company Filing History:
Years Active: 2025
Title: Innovations of Jiaxi He in mRNA Vaccine Development
Introduction
Jiaxi He is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. His work is crucial in the ongoing fight against infectious diseases, including the novel coronavirus.
Latest Patents
Jiaxi He holds a patent for "Compositions and methods of mRNA vaccines against novel coronavirus infection." This patent describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with some embodiments derived from a delta variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use. He has 1 patent to his name.
Career Highlights
Jiaxi He is associated with Rnaimmune, Inc., where he continues to advance research in mRNA technology. His innovative approach has positioned him as a key figure in the development of effective vaccines.
Collaborations
He has collaborated with notable colleagues, including Neeti Ananthaswamy and Yong-Sik Bong, contributing to a dynamic research environment focused on vaccine development.
Conclusion
Jiaxi He's work in mRNA vaccine technology exemplifies the innovative spirit of modern science. His contributions are vital in addressing global health challenges, particularly in the context of the COVID-19 pandemic.